Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

241 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outcomes After Treatment With Cobimetinib in Patients With Rosai-Dorfman Disease Based on KRAS and MEK Alteration Status.
Abeykoon JP, Rech KL, Young JR, Ravindran A, Ruan GJ, Dasari S, Morlote DM, King RL, Rummage C, Zanwar S, Acosta-Medina AM, Tobin WO, Shah MV, Bennani NN, Vassallo R, Ryu JH, Koster MJ, Davidge-Pitts CJ, Witzig TE, Goyal G, Go RS; Mayo Clinic–University of Alabama at Birmingham Histiocytosis Working Group. Abeykoon JP, et al. Among authors: shah mv. JAMA Oncol. 2022 Dec 1;8(12):1816-1820. doi: 10.1001/jamaoncol.2022.4432. JAMA Oncol. 2022. PMID: 36201194 Free PMC article.
Erdheim-Chester Disease.
Shah MV, Go RS. Shah MV, et al. Mayo Clin Proc. 2015 Sep;90(9):1310. doi: 10.1016/j.mayocp.2015.03.019. Mayo Clin Proc. 2015. PMID: 26355408 No abstract available.
Efficacy of biological agents in the treatment of Erdheim-Chester disease.
Goyal G, Shah MV, Call TG, Litzow MR, Wolanskyj-Spinner AP, Koster MJ, Tobin WO, Vassallo R, Ryu JH, Hook CC, Hogan WJ, Go RS. Goyal G, et al. Among authors: shah mv. Br J Haematol. 2018 Nov;183(3):520-524. doi: 10.1111/bjh.14997. Epub 2017 Oct 30. Br J Haematol. 2018. PMID: 29082516 Free article. No abstract available.
Tumor mutational burden and other predictive immunotherapy markers in histiocytic neoplasms.
Goyal G, Lau D, Nagle AM, Vassallo R, Rech KL, Ryu JH, Davidge-Pitts CJ, Tobin WO, Koster MJ, Bennani NN, Shah MV, Liu MC, Go RS; Mayo Clinic Histiocytosis Working Group. Goyal G, et al. Among authors: shah mv. Blood. 2019 Apr 4;133(14):1607-1610. doi: 10.1182/blood-2018-12-893917. Epub 2019 Jan 29. Blood. 2019. PMID: 30696619 Free PMC article. Review. No abstract available.
241 results